Interim report for the period January 1 – September 30, 2024
Reading Time: 5 minutes Strengthened financial position and increased production paceIn the third quarter of 2024, Cinis Fertilizer delivered its first shipload of potassium sulfate to customer Van Iperen International, who in turn resold it to growers in approximately 25 countries worldwide. After the end of
Keturah Announces Campaign for Its Developments, Introduces 5-Year Post-Handover Plan
Reading Time: 2 minutes Dubai, United Arab Emirates: Keturah, the revolutionary global luxury wellbeing real estate and hospitality concept has announced the launch of a sales campaign for The Ritz-Carlton Residences, Dubai, Creekside—part of the Keturah Resort—and Keturah Reserve which runs until 30 December.
Why Homeowners Are Choosing Improving Over Moving
Reading Time: 4 minutes The traditional dream of moving to achieve your dream home goals has lost its lustre in recent years. Instead, many homeowners are now opting to invest in their existing properties in an effort to transform their current spaces into their
Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (26.11.2024)
Reading Time: 2 minutes Kesko Corporation has on 27 November 2024 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 26 November 2024, BlackRock, Inc.’s holding in Kesko Corporation exceeded the
Leqembi[®] launched in South Korea
Reading Time: 4 minutes Stockholm, Sweden, November 28, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult
#24-407 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
#24-408 Delisting of Derivatives from NGM
Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million
Reading Time: 7 minutes Bioretec Ltd Inside information 27 November 2024 at 10.15 p.m. EET THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 27.11.2024
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 27.11.2024 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 27.11.2024 Date 27.11.2024 Exchange transaction Buy Share class ALEX Amount 230 Average price/share 8.8000 EUR Highest
Inside information: Bioretec Ltd launches an accelerated book-building process to raise approximately EUR 5 million through a private placement of new shares
Reading Time: 8 minutes Bioretec Ltd Inside information 27 November 2024 at 6:30 p.m. EET THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN